Taiga Biotechnologies Competitors and Similar CompaniesClear all

Taiga Biotechnologies's competitors and similar companies include Prothena, Trans Genic, Advanced Enzymes and Quality Chemical Laboratories.
Taiga Biotechnologies
Taiga Biotechnologies
Taiga Biotechnologies is a biotech company specializing in therapeutic approaches to treat hematological diseases, including cancers, immunodeficiencies, and autoimmune conditions.
Prothena
Prothena
Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases.
Trans Genic
Trans Genic
Trans Genic (トランスジェニック) is a company engaged in the development and distribution of genetically engineered animals and antibodies and licensing of these activities.
Advanced Enzymes
Advanced Enzymes
Advanced Enzymes is a research company specializing in the manufacturing of enzymes.
Quality Chemical Laboratories
Quality Chemical Laboratories
It provides formulations and manufacturing, raw materials, gas chromatography, organic synthesis, trace metals,
Founding Date
Founding Date
2006
Founding Date
2012
Founding Date
1998
Founding Date
1989
Founding Date
1998
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Aurora, US HQ
Aurora, US
Locations
Dublin, IE HQ
South San Francisco, US
Locations
Chiyoda City, JP HQ
Locations
Thane, IN HQ
Monheim Am Rhein, DE
Malegaon Town, IN
Thane, IN
Chino, US
Locations
Wilmington, US HQ
Employees
Employees
1
Employees
163
Employees
236
Employees
323
Employees
204
Valuation ($)
Valuation ($)
N/A
Valuation ($)
983.1 m
Valuation ($)
25.6 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$9.7m (FY, 2025)
Revenue (est.)
¥13.2b (FY, 2026)
Revenue (est.)
₹6.4b (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
¥10.6b (FY, 2026)
Cost of goods
₹1.6b (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
¥2.6b (FY, 2026)
Gross profit
₹4.8b (FY, 2025)
Gross profit
N/A
Net income
Net income
N/A
Net income
($244.1m) (FY, 2025)
Net income
(¥97.5m) (FY, 2026)
Net income
₹1.3b (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 24m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 18.3m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Prothena
HQ
Dublin, IE
Employees
163

Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases.

View company
Trans Genic
HQ
Chiyoda City, JP
Employees
236

Trans Genic (トランスジェニック) is a company engaged in the development and distribution of genetically engineered animals and antibodies and licensing of these activities.

View company
Advanced Enzymes
HQ
Thane, IN
Employees
323

Advanced Enzymes is a research company specializing in the manufacturing of enzymes.

View company
Quality Chemical Laboratories
HQ
Wilmington, US
Employees
204

It provides formulations and manufacturing, raw materials, gas chromatography, organic synthesis, trace metals,

View company